Krajewska Jolanta, Czarniecka Agnieszka, Jarzab Michał, Kukulska Aleksandra, Hankiewicz-Junak Daria, Hasse-Lazar Kornelia, Gubała Elzbieta, Puch Zbigniew, Paliczka Ewa, Roskosz Józef
Department of Nuclear Medicine and Endocrine Oncology, Comprehensive Cancer Center and M. Sklodowska-Curie Memorial Institute of Oncology, Gliwice Branch, Gliwice.
Endokrynol Pol. 2006 Jul-Aug;57(4):386-91.
The low incidence of relapse in differentiated thyroid carcinoma (DTC), primarily treated by total thyroidectomy and (131)I ablation, stimulates the search for optimal follow-up algorithms which do not include too many tests but are not connected with a risk of missing early recurrence. The aim of the study was to analyze the impact of the routine follow up examinations for early detection of DTC recurrence in low risk DTC patients.
The group consisted of 617 DTC patients diagnosed in 1995-1996. In 513 (83%) total thyroidectomy was performed. 449 (73%) received ablative (131)I therapy. After primary approach complete remission (CR) was stated in 453 (73%), persistent disease in 116 (19%), asymptomatic hyperthyroglobulinaemia in 14 (2%). Patients with CR constituted the low risk group analyzed in this study. The median follow up was 4.16 yrs.
Recurrent disease appeared in 28 (6%) patients (23 locoregional, 9 distant metastases, both in 4). Serum Tg (thyroglobulin) level at the moment of relapse diagnosis was detectable in 44% while neck sonography was the first examination to detect recurrence in 56% of cases.
In the selected group of DTC patients treated by radical primary approach and showing a low risk of recurrence only half of all relapse cases are diagnosed by the rise of serum Tg level. Regular sonography contributes to the second half of diagnoses. Thus, a special weight should be put on neck sonography as the important element of regular follow up in low risk DTC patients.
分化型甲状腺癌(DTC)经全甲状腺切除术和(131)I消融术为主的治疗后复发率较低,这促使人们寻找最佳的随访方案,既不包含过多检查,又不会有漏诊早期复发的风险。本研究旨在分析常规随访检查对低风险DTC患者早期复发检测的影响。
该组包括1995 - 1996年诊断的617例DTC患者。其中513例(83%)接受了全甲状腺切除术。449例(73%)接受了(131)I消融治疗。初次治疗后,453例(73%)达到完全缓解(CR),116例(19%)疾病持续存在,14例(2%)为无症状性甲状腺球蛋白血症。CR患者构成了本研究分析的低风险组。中位随访时间为4.16年。
28例(6%)患者出现疾病复发(23例为局部复发,9例为远处转移,4例两者皆有)。复发诊断时,44%的患者血清Tg(甲状腺球蛋白)水平可检测到,而颈部超声检查是56%病例中首次检测到复发的检查。
在经根治性初次治疗且复发风险较低的DTC患者组中,仅一半的复发病例通过血清Tg水平升高得以诊断。定期超声检查促成了另一半的诊断。因此,应特别重视颈部超声检查,将其作为低风险DTC患者定期随访的重要组成部分。